Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CSPC Pharmaceutical Group...

    OTC: CSPCY · Real-Time Price · USD
    5.32
    -0.02 (-0.47%)
    At close: Aug 21, 2025, 3:59 PM
    5.32
    0.00%
    After-hours: Aug 21, 2025, 04:00 PM EDT

    CSPC Pharmaceutical Income Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 31.65B 23.4B 30.45B 37.96B 46.26B 55.24B 48.19B 49.67B 47.72B 44.61B
    Cost of Revenue
    		 11.19B 8.87B 11.09B 11.1B 13.27B 15.12B 12.9B 12.52B 11.67B 10.99B
    Gross Profit
    		 27.91B 21.98B 26.81B 26.86B 32.99B 40.11B 35.28B 37.16B 36.05B 33.62B
    Operating Income
    		 7.27B 5.48B 7.01B 8.49B 10.28B 12.16B 10.64B 11.1B 10.86B 9.85B
    Interest Income
    		 n/a 141.15M 141.15M 283.08M 384.56M 374.41M 374.41M 322.48M 308.39M 206.58M
    Pretax Income
    		 7.51B 5.61B 7.17B 9.21B 11.11B 13.04B 11.48B 12.05B 12.19B 11.57B
    Net Income
    		 5.93B 4.44B 5.7B 7.4B 8.92B 10.46B 9.21B 9.81B 10.01B 9.48B
    Selling & General & Admin
    		 10.64B 7.92B 10.33B 12.96B 16.68B 20.84B 18.43B 19.98B 19.41B 18.59B
    Research & Development
    		 6.39B 5.14B 6.02B 5.62B 6.19B 7.1B 6.22B 6.08B 5.78B 5.18B
    Other Expenses
    		 1.95B 1.95B 1.97B -39.59M 14.57M 14.57M n/a n/a n/a n/a
    Operating Expenses
    		 18.98B 15.06B 18.36B 18.58B 22.92B 27.95B 24.65B 26.06B 25.19B 23.78B
    Interest Expense
    		 15.73M 22.02M 25.9M 31.27M 35.13M 32.33M 28.45M 19.25M 16.87M 19.51M
    Selling & Marketing Expenses
    		 9.32B 6.96B 9.14B 8.67B 6.54B 4.13B 1.95B n/a n/a n/a
    Cost & Expenses
    		 24.37B 18.12B 23.65B 29.68B 36.2B 43.07B 37.55B 38.57B 36.86B 34.76B
    Income Tax Expense
    		 1.44B 1B 1.28B 1.57B 1.95B 2.37B 2.09B 2.11B 2.08B 1.97B
    Shares Outstanding (Basic)
    		 2.96B 2.96B 2.96B 2.97B 2.97B 2.98B 2.98B 2.98B 2.99B 2.99B
    Shares Outstanding (Diluted)
    		 2.96B 2.96B 2.96B 2.97B 2.97B 2.98B 2.98B 2.98B 2.99B 2.99B
    EPS (Basic)
    		 3.12 3.16 3.04 3.08 3.60 3.52 3.08 3.32 3.36 3.16
    EPS (Diluted)
    		 3.12 3.16 3.04 3.08 3.60 3.52 3.08 3.32 3.36 3.16
    EBITDA
    		 7.97B 5.63B 7.19B 9.23B 11.37B 13.78B 12.21B 12.63B 12.45B 11.34B
    EBIT
    		 7.7B 5.63B 7.16B 7.36B 7.39B 9.36B 7.83B 9.55B 11.06B 9.99B
    Depreciation & Amortization
    		 549.66M 599.65M 634.88M 1.19B 1.69B 1.61B 1.58B 1.54B 1.52B 1.42B

    Add to Watchlist